Featured News
Shaping the Future of Bioanalysis Through Collaboration with EBF
Revolutionizing Bioanalysis with Collaborative Expertise
The bioanalysis industry is undergoing rapid transformation, driven by continuous innovations, and evolving regulatory landscapes. The European Bioanalysis Forum (EBF) remains at the forefront of these changes, fostering critical discussions that help the industry tackle its most complex challenges. We are delighted to lend our experience to thought-leadership pieces produced by the EBF. Through these collaborative efforts, EBF is shaping the way we approach bioanalytical strategies, advising on best practices and challenging outdated or inefficient processes to help ensure continued success in the drug development space.
Many EBF collaborations focus on the re-evaluation of traditional methodologies. A recent example of this was the EBF Autumn Focus Workshop held in 2023, during which industry experts took a big step forward by advocating for an adaptive model that aligns clinical immunogenicity assessments more closely with real-world, context-driven needs. This model redefines clinical immunogenicity from a hurdle to an indicator of pharmacodynamic efficacy. It challenges the status quo of generalized risk assessments and encourages a multi-tiered, patient-focused approach that emphasizes resource efficiency and improved clinical outcomes.
Insights like these are not just relevant for immunogenicity, where evolving risk assessments are leading to better drug development practices, but also for other key areas of bioanalysis that are vital for advancing therapeutic solutions. To stay ahead in this ever-changing landscape, we invite you to explore these curated EBF publications. Each one offers valuable insights into emerging trends and innovations in bioanalysis, including:
Re-thinking the Current Paradigm for Clinical Immunogenicity Assessment: A Update from the Discussion in the European Bioanalysis Forum
Featuring Charles River contributor - John Cook
A European Bioanalysis Forum Recommendation for Requiring a Context-of-use Statement for Successful Development and Validation of Biomarker Assays
Featuring Charles River contributor - Frazer Lambert
How Modern CROs Accelerate Your Drug Development
Are you facing delays, bottlenecks, or rising costs in your drug development process? In this webinar, you will learn how leading CROs overcome these challenges with innovative strategies. Gain insights that can directly impact your timelines, reduce risks, and streamline your path to approval.
Watch the Replay
The EBF are also strong advocates for scientists in the earlier stages of their careers, launching the EBF Young Scientist Symposium in 2014, this community provides an excellent opportunity for young scientists to interact and connect with peers across the bioanalytical industry. We are proud to have our own staff play an active role in this group, and celebrate the success of this initiative:
Feedback from the Science Café Roundtables at the Ninth European Bioanalysis Forum Young Scientist Symposium: Optimizing the Work-life Balance in a Bioanalytical Laboratory
Featuring Charles River contributor - Dean Hogan
We are committed to continued collaboration with organizations such as EBF to share knowledge and help develop strategies that move industry forward. Explore these resources to stay informed on the latest developments and drive success in your bioanalysis efforts.